Consent Management Platform for Life Sciences Success

Executive Summary

A global life sciences organization operating across more than 100 countries needed a single, governed consent platform capable of supporting direct-to-consumer expansion across multiple languages and a complex landscape of privacy regulations, including GDPR, US state privacy laws and HIPAA. Syrenis implemented a geo-aware Consent Management Platform (CMP), a cross-domain consent solution and an identity service to meet these requirements in a single governed environment. The client has since launched its direct-to-consumer offering globally and continues to expand its footprint with Syrenis as its consent infrastructure partner.

Introduction

Few sectors carry greater regulatory weight than life sciences. Organizations in this space operate at the intersection of sensitive health data, direct consumer relationships and some of the most stringent privacy frameworks in existence. When a global life sciences business set out to build a direct-to-consumer model at scale, it faced a consent and preference management challenge that most enterprise platforms are not designed to handle.

The organization operates across more than 100 countries and needed to build a direct-to-consumer model through a single domain, while respecting applicable local privacy laws, supporting multiple languages and maintaining HIPAA compliance for US-based users. This was not a single-market compliance problem. It was a governance challenge requiring precision, consistency and auditability at a global scale.

The Problem

Building a direct-to-consumer model for an organization operating across more than 100 countries on a single domain presents immediate governance complexity. Cookie consent and data collection rules vary significantly across jurisdictions. GDPR applies across the European Economic Area with strict requirements around lawful basis, consent validity and data subject rights. In the United States, state-level privacy laws, including those in California, Virginia, Colorado and others, each carry their own consent and opt-out obligations. A single misstep in how consent is captured or applied can expose an organization to regulatory risk across multiple jurisdictions simultaneously.

The client required a cookie consent solution that could detect a user’s location and apply the correct regulatory framework automatically, without requiring separate implementations for each country or region. It also needed to support the full range of languages in which its consumers operate, ensuring that consent notices were accurate, lawful and accessible across its entire global user base.

Managing Known Users and HIPAA Obligations

The challenge extended beyond anonymous cookie consent. The client also needed to capture and manage consent and communication preferences for known, authenticated users, a distinct requirement that calls for a different technical and governance approach.

In the United States, this became more complex still. Any personal health data collected through direct consumer interactions fell within the scope of the Health Insurance Portability and Accountability Act (HIPAA), which imposes strict rules on how health-related information is collected, stored and shared. The platform needed to enforce HIPAA-compliant consent capture alongside its broader global data privacy obligations, within the same environment.

A further layer of complexity involved consent flows between consumers and healthcare providers (HCPs). In certain situations, consumers needed to authorize the sharing of their information with HCPs directly. This required structured consent capture that could support these exchanges, maintain a clear record of what was consented to and ensure those records were auditable.

Taken together, these three requirements, geo-aware cookie consent across a complex multi-jurisdictional footprint spanning more than 100 countries, identity-linked preference management with HIPAA compliance and HCP consent exchanges, could not be solved with isolated tools or fragmented processes. The client needed a single platform capable of governing all of these consent flows in a consistent, auditable way.

The Solution

Syrenis implemented four core capabilities to address the client’s requirements, each designed to operate within a single governed environment rather than as disconnected point solutions.

Consent Management Platform (CMP). The Syrenis CMP provided the foundation for managing cookie consent across the client’s global domain. It centralized the configuration and deployment of consent notices, giving privacy and legal teams visibility into how consent was being collected and the ability to update policies as regulations evolve.

Geo-Aware Cookie Banner. A geo-aware cookie banner was configured to detect each user’s jurisdiction at the point of interaction and apply the correct regulatory framework automatically. A user accessing the site from Germany received a consent experience aligned with GDPR. A user in California received one aligned with the California Consumer Privacy Act (CCPA) and related state law requirements. This geo-aware logic applied consistently across the organization’s global footprint of more than 100 countries, within a single domain and without requiring separate regional implementations.

The banner was also configured to support multiple languages, ensuring that consent notices were presented accurately in the user’s local language. This is not a cosmetic consideration. Consent must be informed and freely given to be valid under most global privacy frameworks. Language accuracy is a governance requirement, not a localization preference.

Cross-Domain Consent Solution. To manage consent across the organization’s multiple domains, Syrenis implemented its cross-domain consent solution. This carries consent records across the client’s digital properties, so that consent given on one domain is recognized across others. Users are not required to re-consent as they move between the organization’s domains, reducing friction while maintaining a consistent, governed record of customer choices. Consent records were centralized and maintained with full auditability, giving the organization confidence that its records of consent were accurate and defensible.

This capability also supported HIPAA-compliant consent capture for US-based users, ensuring that the collection of health-related information was governed appropriately and that the correct consent mechanisms were applied for regulated data types.

Identity Service. The Syrenis identity service connected consent and preference records to known users, creating a persistent, governed view of each individual’s choices across the client’s ecosystem. A core function of this service was accurate user attribution: identifying whether a visitor was new or returning, even when browser-level tracking restrictions removed that visibility. Safari’s Intelligent Tracking Prevention (ITP) deletes cookies automatically, which breaks the continuity of user recognition. The identity service addressed this by recreating cookies where ITP had removed them, maintaining consistent attribution without compromising the governed record of user consent. This was also essential for managing the HCP consent exchange requirement. When a consumer authorized the sharing of their information with a healthcare provider, that consent was captured, recorded and linked to the correct identity in a way that was auditable and enforceable.

Together, these four capabilities gave the client a single consent infrastructure capable of governing anonymous and known user consent, across multiple regulatory frameworks, at global scale.

Results

The client successfully launched its direct-to-consumer offering globally, with compliant consent management in place across all active markets from day one. A geo-aware consent framework, operating within a single domain, now applies the correct regulatory model to every user interaction automatically, whether the user is accessing the platform from within the European Economic Area under GDPR, a US state with specific opt-out obligations, or any other jurisdiction within the organization’s operating footprint spanning more than 100 countries.

Governance that previously required manual coordination across regional teams is now centralized. Privacy and legal teams have consistent visibility into how consent is captured, applied and recorded across the full global user base. Policy updates are deployed from a single environment rather than managed separately across markets, reducing operational overhead and the risk of inconsistency between jurisdictions.

The cross-domain consent solution removed a significant source of friction for consumers. Users are no longer required to re-consent as they move between the organization’s domains. Consent decisions are recognized and carried across digital properties, maintaining a governed, auditable record of each individual’s choices without creating unnecessary barriers to engagement.

Attribution continuity, previously disrupted by Safari’s Intelligent Tracking Prevention, is now maintained through the identity service. Returning users are correctly recognized even where browser-level cookie deletion would otherwise break that continuity. This gives the organization accurate, reliable data on user behavior across sessions, without compromising its consent governance obligations.

The HCP consent exchange process is now structured, recorded and auditable. When a consumer authorizes the sharing of their information with a healthcare provider, that consent is captured and linked to the correct identity in a way that meets HIPAA requirements and can be produced for regulatory review.

The rollout continues. As the organization expands into additional markets, the consent infrastructure in place is designed to scale alongside it, supporting new regulatory requirements and languages without requiring separate implementations for each new territory.

Across each of these outcomes, the underlying shift is the same: consent governance that once depended on manual coordination, regional workarounds and disconnected tools now operates from a single, centralized environment. Privacy and legal teams can demonstrate, at any point, what consent was captured, under which regulatory framework, in which language and for which individual. That auditability was not available before. The organization now has a defensible, scalable consent foundation, one that supports responsible consumer engagement across a highly regulated global footprint and that continues to extend as new markets are added.

Conclusion

Building a Foundation for Responsible Global Growth

This engagement reflects the operational realities that large, regulated organizations face when expanding into direct-to-consumer models. Cookie consent, preference management, identity resolution and HIPAA compliance are not independent problems. They are interconnected governance requirements that demand a coordinated, auditable approach.

Consent fragmentation, where different tools manage different consent flows without a shared record or governance structure, creates risk that grows with every new market entered. For this client, the priority was establishing a consent infrastructure capable of scaling alongside the business, while maintaining the consistency and auditability that regulated environments require.

As the organization continues its global rollout, the consent framework in place provides the visibility and control needed to add new markets, support new regulatory requirements and maintain trust with the consumers it serves. The relationship between the client and Syrenis continues to develop as new jurisdictions and use cases emerge.

Managing consent and preference data at enterprise scale, across jurisdictions, languages and regulated data types, requires a platform built to handle that complexity from the outset.

Book a demo to see how Syrenis manages consent governance across complex, multi-jurisdictional environments.

Global Life Sciences Firm Achieves Compliant Direct-to-Consumer Expansion